文献速递前列腺增生与排尿功能障碍

前列腺动脉栓塞术的疗效预测:随机非劣效性试验的事后分析

Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial.
PubMed 文献 · BJU Int · 2018-12-17

该事后分析纳入随机开放标签非劣效性试验中接受前列腺动脉栓塞术(PAE)的48例良性前列腺增生伴下尿路症状患者,分析基线特征、PAE技术细节及术后早期指标与12周IPSS、Qmax和前列腺体积变化的关系。结果显示,较大的总前列腺体积和中央腺体体积与IPSS和Qmax改善更显著相关;ROC曲线提示总前列腺体积39mL、中央腺体体积38mL为预测PAE成功的较优阈值;术后疼痛及PSA、CRP水平可能为早期疗效预测因素。

要点

  • 前列腺体积较大者PAE后IPSS和Qmax改善更明显。
  • 总前列腺体积39mL、中央腺体体积38mL为预测IPSS成功的较优阈值。
  • 术后疼痛及PSA、CRP水平可能早期预测PAE疗效。

核心结论

  • 基线及围手术期指标可能有助于指导PAE患者选择和疗效预测,前列腺较大者PAE成功机会更高。

研究设计与样本

  • 随机开放标签非劣效性试验的事后分析,纳入该试验中接受PAE的48例患者。

主要发现

  • 总前列腺体积和中央腺体体积较高与IPSS改善更显著相关(rs分别为-0.35和-0.34;P=0.01和P=0.02)。
  • 总前列腺体积和中央腺体体积较高与Qmax改善更显著相关(rs分别为0.31和0.39;P=0.05和P=0.01)。
  • 中央腺体指数与Qmax改善相关性更明显(rs=0.46,P=0.003)。
  • 前列腺体积相对变化明显依赖于PAE的技术操作。
  • 术后疼痛发生及PSA、CRP血液水平为潜在的PAE早期疗效预测因素。

关键数值与推荐

  • ROC曲线分析提示总前列腺体积39mL为预测PAE成功的较优阈值(以IPSS衡量)。
  • ROC曲线分析提示中央腺体体积38mL为预测PAE成功的较优阈值(以IPSS衡量)。

临床怎么用

  • 可利用基线前列腺体积及中央腺体体积辅助筛选PAE可能获益更大的患者。
  • 术后可关注疼痛、PSA和CRP水平以早期预判疗效。

局限性

  • 为事后分析,样本量48例,需更大规模及更长随访的临床试验进一步明确最适合PAE的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify predictors for different treatment outcomes after prostatic artery embolization (PAE) in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. PATIENTS AND METHODS: A post hoc analysis of data derived from the 48 patients undergoing PAE in a randomized, open-label, non-inferiority trial was performed. Relative changes in the International Prostate Symptoms Score (IPSS), absolute changes in maximum urinary flow rate (Qmax ), and relative changes in magnetic resonance imaging-assessed prostate volume from baseline to 12 weeks were defined as the outcomes measures of interest. Their association with various baseline characteristics and measures, technical details of PAE, and early postoperative measures were analysed using Spearman rank correlations and Wilcoxon rank-sum tests. The most promising predictors were further evaluated in receiver-operating characteristic (ROC) curve analyses. RESULTS: Higher total prostate and central gland (i.e. central plus transitional zone) volumes were associated with more pronounced improvements in the IPSS (Spearman rank correlation [rs]: -0.35 and -0.34; P = 0.01 and P = 0.02, respectively) and the Qmax (rs: 0.31 and 0.39; P = 0.05 and P = 0.01, respectively). ROC curve analyses suggested that volumes of 39 and 38 mL for total prostate and central gland volume, respectively, would be the optimal thresholds with which to predict PAE success as measured by the IPSS. Other anatomical characteristics of the prostate, such as the central gland index, also showed an even more distinct correlation to the improvement in Qmax (rs: 0.46, P = 0.003). The relative changes in prostate volume were clearly dependent on the technical performance of PAE. Occurrence of postoperative pain and blood levels of prostate-specific antigen and C-reactive protein emerged as potential early-stage outcome predictors after PAE. CONCLUSION: Baseline and peri-operative findings might help to guide patient selection and outcome prediction for PAE. Patients with larger prostates have a higher chance of success with PAE. Larger-scale clinical trials including a longer follow-up are warranted to further elucidate the most suitable patients for PAE.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Abt D, Müllhaupt G, Mordasini L, et al. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial. BJU Int. 2018. PMID: 30499637. doi:10.1111/bju.14632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。